H.R. 9788 aims to amend the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to set maximum allowable levels for contaminants in infant formulas. This legislation is intended to enhance the safety and quality of infant nutrition products.
Supporters of H.R. 9788 have praised the bill as a crucial step in protecting the health of infants by ensuring that baby formulas meet stringent safety standards. Advocates argue that establishing maximum contaminant levels will provide parents with greater confidence in the safety of the products they feed their children.
Critics of H.R. 9788 have expressed concerns about potential regulatory overreach and the impact on formula manufacturers. Some argue that the bill could lead to increased production costs, which may ultimately be passed on to consumers, making infant formula less accessible for families.
The analysis of H.R. 9788, which aims to amend the Federal Food, Drug, and Cosmetic Act regarding contaminants in infant formulas, reveals no direct industry overlaps with the sponsor Brian Mast's top donor industries. This suggests that there are minimal immediate conflicts of interest related to the financial backers of the sponsor. Without significant contributions from industries that would be directly impacted by the legislation, the risk of undue influence appears low. Voters should be aware that while the absence of overlaps is a positive indicator, it does not eliminate the potential for indirect influences or future connections as the legislative process unfolds.
Top industries funding Brian Mast, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
